BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3117861)

  • 1. Thrombolytic therapy for unstable angina pectoris: rationale and results.
    Gold HK; Johns JA; Leinbach RC; Yasuda T; Collen D
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):91B-95B. PubMed ID: 3117861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial.
    Williams DO; Topol EJ; Califf RM; Roberts R; Mancini GB; Joelson JM; Ellis SG; Kleiman NS
    Circulation; 1990 Aug; 82(2):376-83. PubMed ID: 2115407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thrombolytic therapy in unstable angina: clinical and angiographic results.
    de Zwaan C; Bar FW; Janssen JH; de Swart HB; Vermeer F; Wellens HJ
    J Am Coll Cardiol; 1988 Aug; 12(2):301-9. PubMed ID: 3134480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis in unstable angina: will the beneficial effects of thrombolytic therapy in myocardial infarction apply to patients with unstable angina?
    Ambrose JA; Alexopoulos D
    J Am Coll Cardiol; 1989 Jun; 13(7):1666-71. PubMed ID: 2656826
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.
    Gold HK; Johns JA; Leinbach RC; Yasuda T; Grossbard E; Zusman R; Collen D
    Circulation; 1987 Jun; 75(6):1192-9. PubMed ID: 3105913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic agents in clinical medicine.
    Verstraete M
    Adv Intern Med; 1988; 33():119-41. PubMed ID: 3125722
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo.
    Freeman MR; Langer A; Wilson RF; Morgan CD; Armstrong PW
    Circulation; 1992 Jan; 85(1):150-7. PubMed ID: 1728444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis in the management of acute myocardial infarction and unstable angina pectoris.
    Loscalzo J
    Drugs; 1989 Feb; 37(2):191-204. PubMed ID: 2649355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis and thrombolysis in unstable angina.
    Brochier ML; Raynaud P; Rioux P; Charbonnier B; Desveaux B; Pacouret G
    Am J Cardiol; 1991 Sep; 68(7):105B-109B. PubMed ID: 1909836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiological insight into the possible optimal therapies for acute myocardial infarction and unstable angina.
    Smalling RW; Anderson HV
    Circulation; 1998 Jan 6-13; 97(1):10-1. PubMed ID: 9443423
    [No Abstract]   [Full Text] [Related]  

  • 11. [Unstable stenocardia: the results of the intracoronary administration of fibrinolytic agents].
    Gratsianskiĭ NA; Panchenko EP; Agapov AA; Logutov IuA; Vladimirov SS
    Kardiologiia; 1986 Jun; 26(6):38-43. PubMed ID: 3761802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unstable angina and thrombolysis.
    Rutherford JD
    Chest; 1990 Apr; 97(4 Suppl):156S-160S. PubMed ID: 2182308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
    Topol EJ; Fuster V; Harrington RA; Califf RM; Kleiman NS; Kereiakes DJ; Cohen M; Chapekis A; Gold HK; Tannenbaum MA
    Circulation; 1994 Apr; 89(4):1557-66. PubMed ID: 8149521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unstable angina or non-Q wave infarction despite long-term aspirin: response to thrombolytic therapy with implications on mechanisms.
    Schreiber TL; Macina G; Bunnell P; Tenney RD; McNulty A; Kikel M; Miller DH; Zola BE; Tracy R; Stump D
    Am Heart J; 1990 Aug; 120(2):248-55. PubMed ID: 2382605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of prolonged low dose recombinant tissue-type plasminogen activator for refractory unstable angina.
    Romeo F; Rosano GM; Martuscelli E; Comito M; Cardona N; Colistra C; Milano B; Bianco C; Rosano V
    J Am Coll Cardiol; 1995 May; 25(6):1295-9. PubMed ID: 7722124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of heparin and systemic lysis on coronary blood flow after reperfusion induced by the novel recombinant plasminogen activator BM 06.022 in a canine model of coronary thrombosis.
    Martin U; Fischer S; Sponer G
    J Am Coll Cardiol; 1993 Sep; 22(3):914-20. PubMed ID: 8354832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary recombinant tissue-type plasminogen activator in unstable angina: a pilot angiographic study.
    DiSciascio G; Kohli RS; Goudreau E; Sabri N; Vetrovec GW
    Am Heart J; 1991 Jul; 122(1 Pt 1):1-6. PubMed ID: 1905873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of anticoagulation, thrombolysis and coronary angioplasty for unstable angina pectoris.
    Topol EJ
    Am J Cardiol; 1991 Sep; 68(7):136B-141B. PubMed ID: 1892061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina.
    Neri Serneri GG; Gensini GF; Poggesi L; Trotta F; Modesti PA; Boddi M; Ieri A; Margheri M; Casolo GC; Bini M
    Lancet; 1990 Mar; 335(8690):615-8. PubMed ID: 1969013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction.
    Kragel AH; Gertz SD; Roberts WC
    J Am Coll Cardiol; 1991 Sep; 18(3):801-8. PubMed ID: 1869744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.